Bayer to purchase gene therapy firm
Bayer agreed to acquire U.S. biotech company Asklepios BioPharmaceutical, commonly known as AskBio, for as much as $4 billion, bolstering its pharma division with experimental gene…
Bayer agreed to acquire U.S. biotech company Asklepios BioPharmaceutical, commonly known as AskBio, for as much as $4 billion, bolstering its pharma division with experimental gene…